NCT06945523 2025-06-04
Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the Treatment of CEA - Positive Advanced Lung Cancer
Chongqing Precision Biotech Co., Ltd
Phase 1 Recruiting
Clinical Trials
6 trialsNCT06992583 2025-05-28
Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer
Chongqing Precision Biotech Co., Ltd
Phase 1 Recruiting
NCT06768151 2025-01-10
A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer
Chongqing Precision Biotech Co., Ltd
Phase 1 Recruiting
NCT04672356 2023-06-22
A Study to Evaluate the Safety , Tolerability and Efficacy of IBI939 in Combination With Sintilimab in Patients With Advanced Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1 Completed
NCT04672369 2023-06-22
A Study to Evaluate the Efficacy of IBI939 in Combination With Sintilimab in Patients With Advanced NSCLC
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1 Completed
NCT03330834 2020-07-13
CAR-T Cell Immunotherapy for Advanced Lung Cancer
Sun Yat-sen University
Phase 1 Terminated